Zhiyuan Yu

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Systematic Design and Evaluation of Nasal Drug Delivery for Central Nervous System Disease from Experimental to Clinical Application.

Systematic Design and Evaluation of Nasal Drug Delivery for Central Nervous System Disease from Experimental to Clinical Application.

Journal: Pharmaceutics

Published: June 17, 2026

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

Journal: Lancet (London, England)

Published: April 14, 2026

Unveiling the "Glycolysis-Lactate-Lactylation" Axis: A Novel Target in Ischemic Cerebrovascular Disease.

Unveiling the "Glycolysis-Lactate-Lactylation" Axis: A Novel Target in Ischemic Cerebrovascular Disease.

Journal: Neuroscience bulletin

Published: October 28, 2025

Regulatory T cells promote microglia-mediated synapse engulfment and functional recovery via the OPN-CD74 axis after spinal cord injury in mice.

Regulatory T cells promote microglia-mediated synapse engulfment and functional recovery via the OPN-CD74 axis after spinal cord injury in mice.

Journal: Journal of neuroinflammation

Published: August 19, 2025

Regulatory T cells attenuate astrogliosis via IL-10/STAT3/PKC/vimentin signaling and promote neurological recovery after spinal cord injury.

Regulatory T cells attenuate astrogliosis via IL-10/STAT3/PKC/vimentin signaling and promote neurological recovery after spinal cord injury.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: August 16, 2025

Transforming Growth Factor β1 Protects Against Ischemic Demyelination via Regulating Microglial Lipid Metabolism Pathway.

Transforming Growth Factor β1 Protects Against Ischemic Demyelination via Regulating Microglial Lipid Metabolism Pathway.

Journal: Stroke

Published: March 31, 2025

Correlation between cerebral small vessel disease and late-life depression: Insights from neuroimaging studies.

Correlation between cerebral small vessel disease and late-life depression: Insights from neuroimaging studies.

Journal: Brain research

Published: March 05, 2025

Endovascular therapy versus best medical care for acute ischemic stroke with distal medium vessel occlusion: a systematic review and meta-analysis.

Endovascular therapy versus best medical care for acute ischemic stroke with distal medium vessel occlusion: a systematic review and meta-analysis.

Journal: Annals of medicine

Published: January 03, 2025

Associations between white matter hyperintensities and physical activity: A sectional study in UK Biobank participants.

Associations between white matter hyperintensities and physical activity: A sectional study in UK Biobank participants.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: December 22, 2024

Retinal vasculature changes as indicators of imaging signs of cerebral small vessel disease: A community-based, cross-sectional study of older adults.

Retinal vasculature changes as indicators of imaging signs of cerebral small vessel disease: A community-based, cross-sectional study of older adults.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: November 17, 2024

Correlations of Plasma Biomarkers and Imaging Characteristics of Cerebral Small Vessel Disease.

Correlations of Plasma Biomarkers and Imaging Characteristics of Cerebral Small Vessel Disease.

Journal: Brain sciences

Published: November 23, 2023

Transforming growth factor-β1 protects against white matter injury and reactive astrogliosis via the p38 MAPK pathway in rodent demyelinating model.

Transforming growth factor-β1 protects against white matter injury and reactive astrogliosis via the p38 MAPK pathway in rodent demyelinating model.

Journal: Journal of neurochemistry

Published: August 22, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026